46 results on '"Pilewski, Joseph M."'
Search Results
2. Update on Lung Transplantation for Cystic Fibrosis
3. Cystic fibrosis: candidate selection and impact of the cystic fibrosis transmembrane conductance regulator therapy
4. Outpatient Pharmacologic Management of Lung Transplant Candidates on the Waiting List
5. Type‐1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction
6. Long-Term Ivacaftor in People Aged 6 Years and Older with Cystic Fibrosis with Ivacaftor-Responsive Mutations
7. Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV‐associated posttransplant lymphoproliferative disorder and worse survival
8. Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation
9. Impact of a Mobile Health Intervention on Long-term Nonadherence After Lung Transplantation: Follow-up After a Randomized Controlled Trial
10. Systems serology in cystic fibrosis: Anti-PseudomonasIgG1 responses and reduced lung function
11. Detrimental Association of Hypogammaglobulinemia With Chronic Lung Allograft Dysfunction and Death Is Not Mitigated by On-Demand Immunoglobulin G Replacement After Lung Transplantation
12. Evaluation of humoral immunity in end-stage lung disease
13. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case–control study in patients with end-stage fibrosis
14. Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications
15. Surgical Strategy for Lung Transplantation in Adults With Small Chests: Lobar Transplant Versus a Pediatric Donor
16. The effects of sialoglycoconjugates on adenovirus-mediated gene transfer to epithelial cells in vitro and in human airway xenografts
17. Lung Transplantation for Cystic Fibrosis
18. Psychiatric Predictors of Long-term Transplant-Related Outcomes in Lung Transplant Recipients
19. Palliative Care and Location of Death in Decedents With Idiopathic Pulmonary Fibrosis
20. E3 Ligase Subunit Fbxo15 and PINK1 Kinase Regulate Cardiolipin Synthase 1 Stability and Mitochondrial Function in Pneumonia
21. Elevated CXCL10 (IP-10) in Bronchoalveolar Lavage Fluid Is Associated With Acute Cellular Rejection After Human Lung Transplantation
22. First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease
23. Ganciclovir-Resistant Cytomegalovirus Infections among Lung Transplant Recipients Are Associated with Poor Outcomes despite Treatment with Foscarnet-Containing Regimens
24. Lung Transplantation After Lung Volume Reduction Surgery
25. Early Major Neurologic Complications After Lung Transplantation
26. Donor Smoking History and Age in Lung Transplantation
27. Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
28. Lung Transplantation for Pulmonary Hypertension
29. Posaconazole Serum Concentrations among Cardiothoracic Transplant Recipients: Factors Impacting Trough Levels and Correlation with Clinical Response to Therapy
30. Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients
31. Experience With Immune Monitoring in Lung Transplant Recipients Correlation of Low Immune Function With Infection
32. CX3CL1 Up-Regulation Is Associated with Recruitment of CX3CR1+Mononuclear Phagocytes and T Lymphocytes in the Lungs during Cigarette Smoke-Induced Emphysema
33. Defining an inhibitory domain in the α-subunit of the epithelial sodium channel
34. Insulin-Like Growth Factor-Binding Protein-5 Induces Pulmonary Fibrosis and Triggers Mononuclear Cellular Infiltration
35. Insulin-Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition
36. The Status of Gene Therapy for Cystic Fibrosis
37. Secreted and Transmembrane Mucins Inhibit Gene Transfer with AAV4 More Efficiently than AAV5*
38. Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma
39. How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease
40. Modulation of adhesion molecules by cytokinesin vivo using human/severe combined immunodeficient (SCID) mouse chimeras
41. Optical or Transbronchial Biopsy to Diagnose Acute Cellular Rejection
42. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR(EXTEND): an open-label extension study
43. The Effects of Sialoglycoconjugates on Adenovirus-Mediated Gene Transfer to Epithelial Cells In Vitroand in Human Airway Xenografts
44. Lessons Learned From Strategy to Become a High-Volume Lung Transplant Center
45. PROSPECTIVE ASSESSMENT OF DIAGNOSTIC UTILITY OF DIFFERENT BRONCHOSCOPY SAMPLING MODALITIES FOR BACTERIAL PNEUMONIA IN LUNG TRANSPLANT RECIPIENTS
46. Finally, mice with CF lung disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.